Categories: News

Job Research Foundation Announces 4th Round of Funding: $400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

NEW YORK, May 18, 2021 /PRNewswire/ — The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each. The grants will be awarded to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at www.jobresearchfoundation.org. Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

MEDIA CONTACT:  Risa B. Hoag, GMGPR, 845-627-3000, 309938@email4pr.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/job-research-foundation-announces-4th-round-of-funding-400-000-in-grants-available-to-researchers-investigating-causestreatments-of-rare-multisystem-immunodeficiency-disorder-301293587.html

SOURCE Job Research Foundation

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago